Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Novocure Ltd Ord Sh (NQ: NVCR )

17.44 -0.21 (-1.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novocure Ltd Ord Sh

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
ROSEN, NATIONAL TRIAL COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVCR
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TriplePoint, NovoCure, UP Fintech, and GDS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Here's Why Novocure Stock Dropped 42% in June
The healthcare company presented the results of an important clinical trial that has mixed implications for its future cash flows. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Friday
  On Friday, 54 companies hit new 52-week lows. 
Via Benzinga
Novocure Announces Favorable Independent Data Monitoring Committee Recommendation to Continue Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy in Pancreatic Cancer
From Novocure
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 40 stocks hit new 52-week lows. 
Via Benzinga
Calling All NovoCure Limited (NVCR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit
New York, New York - Attorney Advertising – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action 
Via Law Firm Newswire
Topics Lawsuit
Exposures Financial Legal
NOVOCURE LIMITED (NASDAQ: NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited
From Bernstein Liebhard LLP
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
  On Monday, 50 companies reached new 52-week lows. 
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TriplePoint, NovoCure, UP Fintech, and GDS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
NOVOCURE LIMITED (NASDAQ: NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TriplePoint, NovoCure, and UP Fintech and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited with Losses Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
ROSEN, NATIONAL TRIAL COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TriplePoint, NovoCure, UP Fintech, and GDS and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
SHAREHOLDER CLASS ACTION REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited (NASDAQ: NVCR)
From Bernstein Liebhard LLP
Via GlobeNewswire
NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
From Lieff Cabraser Heimann & Bernstein, LLP
Via Business Wire
Novocure to Report Second Quarter 2023 Financial Results
From Novocure
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DZS, TriplePoint, NovoCure, and UP Fintech and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of NovoCure Limited (NVCR) Investors and Encourages Investors to Contact the Firm Before August 18, 2023
From Kirby McInerney LLP
Via Business Wire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
From Lieff Cabraser Heimann & Bernstein, LLP
Via Business Wire
NOVOCURE LIMITED (NASDAQ: NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited
Did you lose money on investments in NovoCure Limited? If so, please visit NovoCure Limited Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to... 
From Bernstein Liebhard LLP
Via GlobeNewswire
NovoCure Limited (NVCR) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against NovoCure Limited
From Robbins LLP
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.